Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

A reliable method was created to measure dutasteride and related molecules in capsules.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

MK-5108 is safe and shows potential against tumors, especially alone.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.